Gainers

  • Staar Surgical (NASDAQ:STAA) shares rose 15.3% to $33.9 during Wednesday's after-market session. The company's market cap stands at $1.3 billion. As per the press release, Q1 earnings came out today.
  • Precision Optics Corp (NASDAQ:POCI) shares moved upwards by 15.21% to $5.3. The market value of their outstanding shares is at $49.6 million. As per the news, the Q3 earnings report came out today.
  • Aquestive Therapeutics (NASDAQ:AQST) stock moved upwards by 13.55% to $4.69. The market value of their outstanding shares is at $517.0 million. The company's, Q1 earnings came out today.
  • Psyence Biomedical (NASDAQ:PBM) stock increased by 10.27% to $5.69. The company's market cap stands at $5.6 million.
  • PMV Pharmaceuticals (NASDAQ:PMVP) shares rose 9.3% to $1.41. The company's market cap stands at $75.7 million. As per the press release, Q1 earnings came out yesterday.
  • Quantum Cyber (NASDAQ:QUCY) shares moved upwards by 8.95% to $1.46. The company's market cap stands at $4.0 million.

Losers

  • MDxHealth (NASDAQ:MDXH) shares fell 49.2% to $0.99 during Wednesday's after-market session. The market value of their outstanding shares is at $96.0 million. As per the news, the Q1 earnings report came out today.
  • Doximity (NYSE:DOCS) stock declined by 17.49% to $19.3. The company's market cap stands at $4.9 billion. As per the news, the Q4 earnings report came out today.
  • Sunshine Biopharma (NASDAQ:SBFM) shares decreased by 12.14% to $0.58. The company's market cap stands at $5.1 million.
  • DarioHealth (NASDAQ:DRIO) stock declined by 10.4% to $7.26. The market value of their outstanding shares is at $63.3 million. As per the press release, Q1 earnings came out today.
  • Cuprina Holdings (Cayman) (NASDAQ:CUPR) stock decreased by 10.31% to $0.23. The company's market cap stands at $5.3 million.
  • Gelteq (NASDAQ:GELS) shares decreased by 9.95% to $0.4. The market value of their outstanding shares is at $4.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.